Victoria
Victoria Brown-Kennerly, St. Louis, MO US
Patent application number | Description | Published |
---|---|---|
20120023599 | GENOME EDITING OF CYTOCHROME P450 IN ANIMALS - The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding cytochrome P450 (CYP) proteins. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. The invention also provides zinc finger nucleases that target chromosomal sequence encoding CYP proteins, as well as methods of using the genetically modified animals or cells disclosed herein to screen agents for toxicity and other effects. | 01-26-2012 |
Victoria Caillet, Monnaie FR
Patent application number | Description | Published |
---|---|---|
20100154075 | Nucleic Acids and Proteins Associated with Galactomannan Synthesis in Coffee - Disclosed herein are nucleic acid molecules isolated from coffee ( | 06-17-2010 |
20110263023 | GENES FOR MODULATING COFFEE MATURATION AND METHODS FOR THEIR USE - Disclosed are isolated nucleic acids for modulating coffee maturation. Also disclosed are promoters derived from such genes. Methods for using the nucleic acids for improving quality attributes of coffee are provided. Also provided are methods for assessing the quality of plant-based agricultural products, such as coffee. | 10-27-2011 |
Victoria Caparros Cabezas, Zurich CH
Patent application number | Description | Published |
---|---|---|
20130007375 | DEVICE AND METHOD FOR EXCHANGING DATA BETWEEN MEMORY CONTROLLERS - A device with an interconnect having a plurality of memory controllers for connecting the plurality of memory controllers. Each memory controller of the plurality of memory controllers is coupled to an allocated memory for storing data. Further, each memory controller of the plurality of memory controllers has one accelerator of a plurality of accelerators for mutually exchanging data over the interconnect. | 01-03-2013 |
20130007398 | DEVICE AND METHOD FOR EXCHANGING DATA BETWEEN MEMORY CONTROLLERS - A device with an interconnect having a plurality of memory controllers for connecting the plurality of memory controllers. Each memory controller of the plurality of memory controllers is coupled to an allocated memory for storing data. Further, each memory controller of the plurality of memory controllers has one accelerator of a plurality of accelerators for mutually exchanging data over the interconnect. | 01-03-2013 |
20130159632 | MEMORY SHARING BY PROCESSORS - A method of memory sharing implemented by logic of a computer memory control unit, the control unit comprising at least one first interface and second interfaces and is adapted to be connected with a main physical memory via the first interface, and a set of N≧2 non-cooperative processors via the second interfaces, the logic operatively coupled to the first and second interfaces. The method includes receiving, via the second interfaces, a request to access data of the main physical memory from a first processor of the set; evaluating if a second processor has previously accessed the data requested by the first processor; and deferring the request from the first processor when the evaluation is positive, or, granting the request from the first processor when the evaluation is negative. | 06-20-2013 |
Victoria Chou, Washington, DC US
Patent application number | Description | Published |
---|---|---|
20090092567 | OIL-CONTAINING COMPOSITIONS EXHIBITING REDUCED FEATHERING - The invention relates to compositions containing at least one oil, at least one silicone elastomer, at least one wax, at least one filler, and at least one coloring agent as well as to methods of making and using such compositions. | 04-09-2009 |
Victoria Clark, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090217774 | Torque sensing apparatus - There is described an apparatus for providing rotary displacement information indicative of the torque applied to a torsion bar which is rotatable relative to a housing, in which the electromagnetic coupling between a transmit aerial fixed relative to the housing and a receive aerial fixed relative to the housing varies in dependence upon first and second resonators fixed to the torsion bar at spaced axial positions. The first and second resonators have respective different resonant frequencies to enable the signal coupled between the transmit aerial and the receive aerial via the first resonator to be distinguished from the signal coupled between the transmit aerial and the receive aerial via the second resonator. | 09-03-2009 |
Victoria Cortessis, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100124747 | COMPOSITIONS AND METHODS FOR DIAGNOSIS OR PROGNOSIS OF TESTICULAR CANCER - Provided are compositions and methods for diagnosis or prognosis of testicular or male germ-cell derived cancer, comprising: obtaining sperm DNA from a test subject; determining the methylation status of at least one CpG dinucleotide sequence of at least one gene sequence selected from HRAS, NTF3, MT1A, PAX8, DIRAS3, PLAGL1, SFN, SAT2CHRM1, MEST, RNR1, CYP27B1 and ICAM1; and thereby determining or diagnosing testicular or male germ-cell derived cancer. Provided are compositions and methods for identifying agents that cause testicular or male germ-cell derived cancer, comprising: obtaining human ES-cell derived primordial germ cells; contacting the germ cells or descendants thereof, with a test agent; culturing the contacted cells; determining, using a genomic DNA of the sample, the methylation status of at least one CpG dinucleotide sequence of at least one gene sequence selected from the above group; and identifying at least one test agent that causes testicular or male germ-cell derived cancer. | 05-20-2010 |
Victoria Dekoster, New Rochelle, NY US
Patent application number | Description | Published |
---|---|---|
20090325464 | BRA STRAP WITH STABILIZING MATERIAL - A stabilizing shoulder strap for an upper torso garment is provided, having enhanced stability in the shoulder region. The stabilizing shoulder strap has a first end, a second end, and an intermediate shoulder portion in between the first end and the second end. The intermediate shoulder portion may have a greater width than the first end and the second end of the stabilizing shoulder strap. A panel is attached to opposing longitudinal edges of the intermediate portion of the stabilizing shoulder strap, and may be more rigid than the intermediate shoulder portion to which it is attached, thereby providing improved stability to the shoulder strap. | 12-31-2009 |
Victoria De La Huerga, Union, KY US
Patent application number | Description | Published |
---|---|---|
20090104320 | Stabilization of Milk-Based Products - Dairy-derived food products, particularly beverages, such as milk/juice blends, yogurt-based drinks, fermented milk beverages, and soft drinks, are disclosed. These compositions contain a stabilizing mixture comprising metal (in the form of ions, salts or oxides) such as zinc or magnesium, either alone or together with an adjunct component such as ascorbic acid. These beverage products do not form off-flavors when they are exposed to sunlight or fluorescent light. This provides for more efficient and inexpensive manufacture of the products and eliminates the need for expensive opaque packing materials. | 04-23-2009 |
Victoria Dellanos, Naples, FL US
Patent application number | Description | Published |
---|---|---|
20130068142 | Beach picnic table - The inventive concept is a picnic table for use on a beach or any desired location. The table is constructed of a molded plastic in a round configuration, although any configuration can be used. The table is supported by central support stake that is being pushed into the ground to stabilize the same. The stake is removably attached to a circular flange under the table in its center. The central support is constructed as a round stake which is made of two telescoping sections. The sections can each be stored on the underside of the table in respective clamps. | 03-21-2013 |
Victoria Demina, Bonn DE
Patent application number | Description | Published |
---|---|---|
20140309408 | METHOD FOR PURIFYING VIRUS-LIKE PARTICLES (VLP) - The invention relates to a method for purifying compositions containing virus-like particles (VLP), wherein a VLP-containing composition is filtered through a filter medium, in particular through a membrane, having a molecular weight cut off (MWCO) of more than 30 kDa, and the cell culture supernatant of VLP-expressing cells is used as a VLP-containing composition. The invention further relates to a VLP-containing composition which can be produced by this method. | 10-16-2014 |
20150045417 | A NOVEL DRUG DELIVERY SYSTEM BASED ON JCV-VLP - The invention relates to VLP derived from human polyoma virus loaded with a drug (cargo) as a drug delivery system for transporting said drug into the CNS, in particular of living humans. | 02-12-2015 |
Victoria Doseeva, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20100285473 | THERMOPHILIC HELICASE DEPENDENT AMPLIFICATION TECHNOLOGY WITH ENDPOINT HOMOGENOUS FLUORESCENT DETECTION - Disclosed herein are methods of amplifying a target nucleic acid in a helicase-dependent reaction. Also disclosed are methods of amplifying and detecting a target nucleic acid in a helicase-dependent reaction as well as modified detection labels to assist in the detection. | 11-11-2010 |
Victoria Ferragut Perez, Cerdanyola Del Valles ES
Patent application number | Description | Published |
---|---|---|
20130243644 | CONTINUOUS SYSTEM AND PROCEDURE OF STERILIZATION AND PHYSICAL STABILIZATION OF PUMPABLE FLUIDS BY MEANS OF AN ULTRA-HIGH PRESSURE HOMOGENIZATION - Continuous system and procedure of sterilization and physical stabilization of pumpable fluids, food, or other type of fluids, through ultra-high pressure homogenization (UHPH) includes a first heat exchanger | 09-19-2013 |
Victoria Gomez-Roldan, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20110230352 | TREATMENT PROCESS FOR A SUPERIOR PLANT IN ORDER TO CONTROL ITS GROWTH AND ARCHITECTURE - A treatment process for a superior plant in order to control the growth of the plant, is characterized in that an adapted quantity of strigolactones is brought in contact with the plant so as to inhibit the formation of at least one ramification. A method of using strigolactones to identify genes and/or molecules involved in the growth of buds and/or ramifications in superior plants is also disclosed. | 09-22-2011 |
Victoria Haritos, O'Connor AU
Patent application number | Description | Published |
---|---|---|
20110269205 | USE OF ENZYME CATALYSTS IN CO2 PCC PROCESSES - A method for processing a stream enriched in CO | 11-03-2011 |
Victoria Hilborne, London GB
Patent application number | Description | Published |
---|---|---|
20110054801 | Detecting a Chemical Impurity - The invention is a detector ( | 03-03-2011 |
Victoria Homblower, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20100041005 | Tissue-mimicking phantom for prostate cancer brachytherapy - A phantom for prostate cancer brachytherapy has a prostate tissue phantom shaped like a real prostate gland, a perineal tissue phantom surrounding the prostate tissue phantom, a skin tissue phantom separating the perineal tissue phantom from an outside environment, and an enclosure. The prostate tissue phantom is a polyvinyl alcohol cryogel (PVA-C) having undergone 3-5 freeze-thaw cycles and having 10-20% w/w PVA in a solvent (e.g. water), 4-8% w/w oil and an amount of acoustic scattering particles to ultrasonically distinguish the prostate-tissue phantom from its surroundings. The perineal tissue phantom is a PVA-C having undergone 1-2 freeze-thaw cycles and having 10-20% w/w PVA in a solvent, 4-8% w/w oil and an amount of acoustic scattering particles to ultrasonically distinguish the perineal tissue phantom from its surroundings. The skin tissue phantom is a PVA-C having undergone at least 6 freeze-thaw cycles and having 15-25% w/w PVA in a solvent. The phantom mimics the imaging and mechanical properties of the prostate and surrounding tissues, providing a realistic phantom for prostate cancer brachytherapy. | 02-18-2010 |
Victoria Ironmonger, Tonbridge GB
Patent application number | Description | Published |
---|---|---|
20140200218 | NOVEL CRYSTALLINE FORMS OF (3R, 6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-[(1R)-1-(2,6-DIMETHYL-3-PYRIDINYL)-2-- (4-MORPHOLINYL)-2-OXOETHYL]-6-[(1S)-1-METHYLPROPYL]-2,5-PIPERAZINEDIONE - Disclosed are crystalline forms of (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione benzenesulfonate salt and pharmaceutical compositions thereof. Also disclosed are processes for the preparation the above compounds and methods for use thereof. | 07-17-2014 |
Victoria James, Cardiff GB
Patent application number | Description | Published |
---|---|---|
20140011907 | COMPOSITIONS CONTAINING PHOSPHATE CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS - A composition is capable of curing via condensation reaction. The composition uses a phosphate condensation reaction catalyst. The phosphate condensation reaction catalyst is used to replace conventional tin catalysts. The composition can react to form a gum, gel, or rubber. | 01-09-2014 |
20140018467 | COMPOSITIONS CONTAINING SULFONIC ACID CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS - A composition is capable of curing via condensation reaction. The composition uses a sulfonic acid condensation reaction catalyst. The sulfonic acid condensation reaction catalyst is used to replace conventional tin catalysts. The composition can react to form a gum, gel, or rubber. | 01-16-2014 |
20140018485 | CONDENSATION REACTION CURABLE SILICONE ORGANIC BLOCK COPOLYMER COMPOSITION CONTAINING A SILYL PHOSPHATE CATALYST AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITION - A condensation reaction curable composition comprises a silyl phosphate catalyst, and a polyorganosiloxane polyoxyalkylene block copolymer having one or more polyorganosiloxane blocks and one or more polyoxyalkylene blocks linked to each other via divalent radicals which comprises at least two silicon-bonded alkoxy groups, preferably of the form PS-(A-PO) | 01-16-2014 |
20140039089 | Compositions Containing Phosphonate Catalysts And Methods For The Preparation And Use Of The Compositions - A composition is capable of curing via condensation reaction. The composition uses a phosphonate condensation reaction catalyst. The phosphonate is used to replace conventional tin catalysts. The composition can react to form a gum, gel, or rubber. | 02-06-2014 |
Victoria Jane Smyth, Belfast GB
Patent application number | Description | Published |
---|---|---|
20120141979 | OLIGONUCLEOTIDES FOR DETECTING CHICKEN ASTROVIRUS - There is provided an oligonucleotide sequence capable of binding to a portion of a CAstV genome, wherein the oligonucleotide sequence has binding specificity to the precapsid region of CAstV or to cDNA of the precapsid region. The oligonucleotide sequence can be one of a primer pair for use in a method for detecting the presence of CAstV in a biological sample by reverse transcription followed by amplification of the reverse transcription products using such primer pair, or a method for amplifying CAstV cDNA using such primer pair. | 06-07-2012 |
Victoria Jimenez Tentor, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100047276 | Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids - Recombinant vectors which are based on the Modified Ankara Virus (MVA) as preventive and therapeutic vaccines against AIDS. The recombinant viruses object of the invention contain sequences which are inserted at the same MVA insertion site and which enable the simultaneous expression of various antigens, a HIV-1 Env protein consisting of a gp120 protein lacking sequences corresponding to protein gp 41 and a chimeric fusion protein of Gag, Pol and Nef. Said viruses are stable and can trigger immune responses against a large variety of antigens. Those viruses having a chimeric protein that derives from sequences of HIV-1 are suitable for the preparation of preventative or therapeutic vaccines against AIDS, particularly for use as vaccination protocols comprising various doses and different vectors, as demonstrated by assays performed using other vectors from the invention, having the same genome organization, but a chimeric protein that derives from sequences of pathogenic SHIV | 02-25-2010 |
Victoria Kabluyen, Las Vegas, NV US
Patent application number | Description | Published |
---|---|---|
20140353356 | Stapler for Use with Distinctively Shaped Staples - The invention generally pertains to a stapler for applying a distinctively shaped staple to a receiving body, such as a plurality of paper pages. The distinctively shaped staple typically comprises a shaped face top member coupled to a plurality of straight legs. The stapler generally comprises a base plate provided with an anvil for bending the straight legs of the distinctively shaped staple, a staple magazine pivotally connected to the other end of the base plate to be pivotal with respect to the base plate sized and configured to receive and dispense a plurality of distinctively shaped staples, and an actuating lever pivotally connected to the staple magazine and also pivotal with respect to the base plate. The actuating lever is configured to actuate a staple driver to drive a distinctively shaped shaped staple from the staple magazine into the receiving body. | 12-04-2014 |
Victoria Lages, Pont A Mousson FR
Patent application number | Description | Published |
---|---|---|
20130108787 | Facility for Coating the Inside of a Pipe Element and Corresponding Use | 05-02-2013 |
Victoria Lapina, Minsk BY
Patent application number | Description | Published |
---|---|---|
20120088229 | SURFACE PLASMON RESONANCE SENSOR - The application relates to a sensor using a gold layer ( | 04-12-2012 |
Victoria Livschitz, San Ramon, CA US
Patent application number | Description | Published |
---|---|---|
20100211508 | SYSTEM AND METHOD FOR ENABLING SERVICE TRANSACTIONS - The present invention provides a computer-based system and method for brokering transactions between sellers and a buyer of goods or services, the system including computer having the requisite software and hardware to provide a database, a provider portal, and a consumer portal. Preferably, the database contains a hierarchical listing of services being offered and options and information associated with them. The provider portal and consumer portal are configured to gather specified information so that a transaction based on the information can be formed. | 08-19-2010 |
Victoria Llado Canellas, Palma De Mallorca ES
Patent application number | Description | Published |
---|---|---|
20120108550 | Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments - Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state. | 05-03-2012 |
Victoria Lladó Cañellas, Palma De Mallorca ES
Patent application number | Description | Published |
---|---|---|
20110294883 | ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS INTENDED FOR USE AS A DRUG - Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines. | 12-01-2011 |
Victoria López Rodas, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100248286 | BIOSENSORS BASED ON MICROALGAE FOR THE DETECTION OF ENVIRONMENTAL POLLUTANTS - The present invention provides biosensors based on microalgae for the determination of the presence of toxic compounds in a sample, characterized by the high sensitivity and specificity thereof with respect to the target toxic substance. The biosensors are based on the measurement of the photosynthetic activity of algae by means of monitoring the molecular oxygen production by the microalgae by using a luminescent compound the emission of which depends on the amount of oxygen in the medium. | 09-30-2010 |
Victoria López Rodas, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100248286 | BIOSENSORS BASED ON MICROALGAE FOR THE DETECTION OF ENVIRONMENTAL POLLUTANTS - The present invention provides biosensors based on microalgae for the determination of the presence of toxic compounds in a sample, characterized by the high sensitivity and specificity thereof with respect to the target toxic substance. The biosensors are based on the measurement of the photosynthetic activity of algae by means of monitoring the molecular oxygen production by the microalgae by using a luminescent compound the emission of which depends on the amount of oxygen in the medium. | 09-30-2010 |
Victoria Magrioti US
Patent application number | Description | Published |
---|---|---|
20110136879 | COMPOUND - The invention provides compounds of formula (I) | 06-09-2011 |
Victoria Magrioti, Athens GR
Patent application number | Description | Published |
---|---|---|
20110105610 | Phospholipase A2 Inhibitors and their Use in Treating Neurological Injury and Disease - Phospholipase A | 05-05-2011 |
Victoria Mceaneney, Dublin IE
Patent application number | Description | Published |
---|---|---|
20110124554 | Fibrosuppressant Biotherapeutics - The invention relates to IHG-1 (induced by high glucose-1) a novel gene which encodes a protein that amplifies fibrotic responses in in vitro and in vivo models of fibrotic disorders and in human diabetic nephropathy. In particular the invention relates to modifications of the IHG-1 structure which are potential fibrosuppressant biotherapeutics and modify cellular invasiveness. The invention also relates to a method of screening a therapeutic agent for suitability for the treatment of fibrotic disease comprising testing a candidate therapeutic agent for the ability to reduce the expression of IHG-1 levels in a model system. | 05-26-2011 |
20140213528 | Fibrosuppressant Biotherapeutics - The invention relates to IHG-1 (induced by high glucose-1) a novel gene which encodes a protein that amplifies fibrotic responses in in vitro and in vivo models of fibrotic disorders and in human diabetic nephropathy. In particular the invention relates to modifications of the IHG-1 structure which are potential fibrosuppressant biotherapeutics and modify cellular invasiveness. The invention also relates to a method of screening a therapeutic agent for suitability for the treatment of fibrotic disease comprising testing a candidate therapeutic agent for the ability to reduce the expression of IHG-1 levels in a model system. | 07-31-2014 |
Victoria Moneo Ocaña, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130266666 | Combination Therapy with an Antitumor Alkaloid - The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer. | 10-10-2013 |
Victoria Moneo Ocaña, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130266666 | Combination Therapy with an Antitumor Alkaloid - The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer. | 10-10-2013 |
Victoria Murday, Glasgow GB
Patent application number | Description | Published |
---|---|---|
20100203535 | GENETIC ANALYSIS - The present invention provides methods for excluding a gene as being involved in, associated with or causative of a genetic disorder in a family. | 08-12-2010 |
Victoria Nikiforova, Werder DE
Patent application number | Description | Published |
---|---|---|
20130295692 | MEANS AND METHODS FOR PREDICTING DIABETES - A method for diagnosing diabetes or a predisposition for diabetes is provided, which comprises determining the amount of glyoxylate in a test sample of a subject suspected to suffer from diabetes or to have a predisposition for diabetes and comparing said amount to a references, whereby diabetes or a predisposition for diabetes is to be diagnosed. Further, the use of glyoxylate or a detection agent for glyoxylate for diagnosing diabetes or a predisposition for diabetes is provided. Moreover, a device and a kit for diagnosing diabetes or a predisposition for diabetes are also provided. | 11-07-2013 |
Victoria Palmer Skebba, Cedarburg, WI US
Patent application number | Description | Published |
---|---|---|
20100272690 | Antimicrobial Compositions and Related Methods of Use - Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications. | 10-28-2010 |
20130302480 | Antimicrobial Compositions and related methods of use - Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and, applications. | 11-14-2013 |
20140322423 | Restructured Natural Protein Matrices - Methods as can be used in the preparation of one or more dairy, dairy analog and cheese products from a range of proteinacous starting materials, such methods comprising protein modification and protein restoration or protein restructure. | 10-30-2014 |
20150073048 | Antimicrobial Compositions and Related Methods of Use - Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications. | 03-12-2015 |
Victoria Perreau, Coburg Vic AU
Patent application number | Description | Published |
---|---|---|
20110064669 | USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS - The present invention relates generally to a method for the treatment and prophylaxis of neurodegenerative diseases and conditions. More particularly, the present invention contemplates the treatment or prophylaxis of neurological conditions involving oligodendrocyte cytotoxicity or cell cycle arrest, demyelination and/or axonal or neuronal degeneration. Agents, medicaments and pharmaceutical compositions useful in the treatment and prophylaxis of neurodegenerative conditions and disorders also form part of the present invention. | 03-17-2011 |
Victoria Petitt, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20100171010 | MAT BOARD CORNER SAMPLE DISPLAY AND ORGANIZING SYSTEM - A matboard corner sample display system. The system includes a caddy that holds matboard corner samples such that one leg of the matboard is vertical and perpendicular to the outwardly extending second leg. The caddy includes a base, an inner vertical support attached thereto, and an outer vertical support. The inner and outer vertical supports are shaped in an arc and disposed concentrically such that a channel is formed between the inner and outer vertical support. The caddy can be shaped as a closed arc and divided into two sections that are pivotally connected by a hinge. The two sections can be separated by opening the hinge to allow a matboard corner samples in each sections to be positioned without physically interfering. | 07-08-2010 |
Victoria Piunova, Altadena, CA US
Patent application number | Description | Published |
---|---|---|
20130296491 | Periodic Nanostructures From Self Assembled Wedge-Type Block-Copolymers - The invention provides a class of wedge-type block copolymers having a plurality of chemically different blocks, at least a portion of which incorporates a wedge group-containing block providing useful properties. For example, use of one or more wedge group-containing blocks in some block copolymers of the invention significantly inhibits chain entanglement and, thus, the present block copolymers materials provide a class of polymer materials capable of efficient molecular self-assembly to generate a range of structures, such as periodic nanostructures and microstructures. Materials of the present invention include copolymers having one or more wedge group-containing blocks, and optionally for some applications copolymers also incorporating one or more polymer side group-containing blocks. The present invention also provides useful methods of making and using wedge-type block copolymers. | 11-07-2013 |
20130324666 | RAPID SELF-ASSEMBLY OF BLOCK COPOLYMERS TO PHOTONIC CRYSTALS - The invention provides a class of copolymers having useful properties, including brush block copolymers, wedge-type block copolymers and hybrid wedge and polymer block copolymers. In an embodiment, for example, block copolymers of the invention incorporate chemically different blocks comprising polymer size chain groups and/or wedge groups that significantly inhibit chain entanglement, thereby enhancing molecular self-assembly processes for generating a range of supramolecular structures, such as periodic nanostructures and microstructures. The present invention also provides useful methods of making and using copolymers, including block copolymers. | 12-05-2013 |
20140011958 | PHOTONIC STRUCTURES FROM SELF ASSEMBLY OF BRUSH BLOCK COPOLYMERS AND POLYMER BLENDS - The invention provides a class of block copolymers having a plurality of chemically different blocks, at least a portion of which incorporating polymer side chain groups having a helical secondary structure. The invention also provides structures generated by self-assembly of polymer blends including at least one block copolymer component, such as a brush block polymer or wedge-type block polymer. The invention provides, for example, periodic nanostructures and microstructures generated by self-assembly of block copolymers and polymer blends comprising a mixture of at least one block copolymer component, such as a brush block copolymer, and at least a second component. | 01-09-2014 |
20140243483 | Chiral Polymers for the Self-Assembly of Photonic Crystals - Described herein are copolymers constructed from chiral, non-racemic monomers, which self-assemble to photonic crystals. The difficulty of incorporating chiral elements into photonic crystals has limited the ability to generate unique bandstructures for different circular polarizations of light. The materials and methods described herein relate to easily, predictably fabricating chiral photonic crystals having desirable optical properties. | 08-28-2014 |
Victoria Polonis, Silver Spring, MD US
Patent application number | Description | Published |
---|---|---|
20140220107 | TRUNCATED HIV ENVELOPE PROTEINS (ENV), METHODS AND COMPOSITIONS RELATED THERETO - The instant application provides methods and related compositions pertaining to novel HIV envelope proteins. In some embodiments, the invention relates to methods and compositions for the preparation, production, and administration of isolated novel HIV envelope nucleic acid and protein sequences suitable, for example, as vaccines against HIV. | 08-07-2014 |
Victoria Polubinska, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20120240084 | Graphic User Interface for Interactions with Datasets and Databases and a Method to Manage Information Units - Methods for data visualisation, browsing, entry, modification, querying, processing, storage and transfer are described herein. | 09-20-2012 |
Victoria Reichel, Graz AT
Patent application number | Description | Published |
---|---|---|
20140363837 | Horseradish Peroxidase Isoenzymes - The present invention relates to recombinant heme-containing horseradish peroxidase isoenzymes with improved properties. In particular, the present invention relates to a plant enzyme kit comprising recombinant peroxidase isoenzymes, preferably horseradish peroxidase isoenzymes. | 12-11-2014 |
20150053614 | Degradation of Hormones Using Recombinant HRP Isoenzymes - The present invention relates to the use of recombinant heme-containing horseradish peroxidase isoenzyme with improved technological properties such as altered glycosylation, improved catalytic properties or improved stability and different ranges of pH optima and improved surface interactions in the treatment of waste water. | 02-26-2015 |
Victoria Repice, New York, NY US
Patent application number | Description | Published |
---|---|---|
20120239758 | SYSTEM AND METHOD FOR CONSUMER-TO-CONSUMER LENDING OF DIGITAL CONTENT - A consumer-to-consumer lending system and method for digital content such as digital ebooks. The lending system invention enables a user who has purchased digital content to lend that content to another user. The lending system enables a lender to extend a lending offer to a lendee and a lendee to respond to the lending offer. A lendee may accept or reject a lending offer. Upon acceptance, the lending system provides the lent content to the lendee who controls the content until returning it, purchasing it or until a predetermined lending period expires. During the lending period the lender does not have access to the lent digital content item. The lending system assists a lender with initiating a lending offer, such as providing a pre-populated email form, and delivers the lend offer notification to the target lendee. Lending offers may be initiated and notifications received over common channels, including email systems, mobile devices, and web-based user accounts. The lending process can be initiated directly from a consumer device. | 09-20-2012 |
Victoria Repice, Manalapan, NJ US
Patent application number | Description | Published |
---|---|---|
20110206023 | IN-STORE READING SYSTEM - A system and method for providing digital data content to a wireless device. Although a fee is typically charged for access to the digital data content, e.g., electronic books, the system and the method provides controlled access to this content for free while the wireless device is accessing the content in a specified location, e.g., a retail location. A content control server receives a request from the wireless device requesting access to the digital data content. The request is received over a secure connection, preferably a virtual private network (VPN). The content control server monitors how much of the digital data content has been provided to the wireless device, and/or an amount of time the wireless device has been accessing the digital data content. This content control server uses this monitored data to control, throttle, the provision of the digital data content to the wireless device. | 08-25-2011 |
Victoria Repice, Dallas, TX US
Patent application number | Description | Published |
---|---|---|
20130281077 | Service management platform for configuring, monitoring, and managing mobile devices - A service management platform provides a manager device the ability to provision, manage, and monitor managed devices through a manager device interface to the service management platform. The service management platform allows for a manager device to configure and modify various profiles by determining one or more governing policies to be associated with respective profiles. The service management platform allows for the manager device to provision managed devices by the service management platform applying selected profiles to respective selected devices. The service management platform further allows for the manager device to monitor one or more managed devices by providing managed device usage data to the manager device, based on requests originating at the manager device. | 10-24-2013 |
Victoria Rimkunas, Somerville, MA US
Patent application number | Description | Published |
---|---|---|
20120093837 | COMPOSITIONS AND METHODS FOR DETECTING EGFR IN CANCER - The invention discloses binding agents to the E746-A750 deletion and the L858R point mutations in the epidermal growth factor receptor (EGFR) molecule, and methods for use thereof, including methods for the diagnosis and treatment of cancer. | 04-19-2012 |
Victoria Rodellar Biarge, Madrid ES
Patent application number | Description | Published |
---|---|---|
20140122063 | METHOD AND SYSTEM FOR ESTIMATING PHYSIOLOGICAL PARAMETERS OF PHONATION - The invention consists of a method and computing system for recording and analyzing the voice which allows a series of parameters of phonation to be calculated. These transmit relevant information regarding effects caused by organic disorders (which affect the physiology of the larynx) or neurological disorders (which affect the cerebral centers of speech). The classification methods are also considered an essential part of the invention which allow estimations of the existing dysfunction to be obtained and for the allocation of personality. The usefulness of the invention lies in the possibility of applying the dysfunction estimation in primary care service centers for patient screening to specialist care centers, simplifying examination protocols, saving costs and reducing waiting lists. This methodology can also be used for detecting the personality of a speaker by their voice, allowing access to installations or services. | 05-01-2014 |
Victoria Rogers, Pleasanton, CA US
Patent application number | Description | Published |
---|---|---|
20140174957 | Ophthalmic Devices For Delivery Of Beneficial Agents - Contact lenses comprising phosphorylcholine groups release beneficial polyionic or guanidinium-containing agents. | 06-26-2014 |
20140174962 | Silicone Hydrogel Contact Lenses For Sustained Release Of Beneficial Polymers - Silicone hydrogel contact lenses comprising an ionic component sustain release of beneficial cationic polymers. | 06-26-2014 |
20140178327 | Antimicrobial Ophthalmic Devices - Antimicrobial ophthalmic devices such as contact lenses, ocular inserts, ocular bandages, and intraocular lenses comprise a hydrogel and an antimicrobially-effective amount of epsilon polylysine non-covalently attached to the hydrogel. | 06-26-2014 |
20140179825 | Methods Of Manufacturing Contact Lenses For Delivery Of Beneficial Agents - Contact lenses comprising an ionic component are packaged with a beneficial cationic agent in a temperature-sensitive packaging solution and/or a low ionic strength packaging solution. | 06-26-2014 |
Victoria Rydengard, Vellinge SE
Patent application number | Description | Published |
---|---|---|
20120189673 | POLYPEPTIDES AND USES THEREOF - The present invention provides polypeptides comprising or consisting of an amino acid sequence derived from a naturally occurring protein which modulates blood coagulation, or a fragment, variant, fusion or derivative thereof, or a fusion of said fragment, variant or derivative thereof, for use in the treatment or prevention of inflammation and/or excessive coagulation of the blood. Related aspects of the invention provide isolated polypeptides comprising or consisting of an amino acid sequence of SEQ ID NOs: 1 to 11, or a fragment, variant, fusion or derivative thereof, or a fusion of said fragment, variant or derivative thereof which exhibit an anti-inflammatory and/or anti-coagulant activity, together with isolated nucleic acid molecules, vectors and host cells for making the same. Additionally provided are pharmaceutical compositions comprising a polypeptide of the invention, as well as methods of use of the same in the treatment and/or prevention of inflammation and/or excessive coagulation. | 07-26-2012 |
Victoria San AndrÉs Aura, Moncada (valencia) ES
Patent application number | Description | Published |
---|---|---|
20110119788 | METHOD FOR GENERATING RESISTANCE AGAINST CITRUS DISEASES CAUSED BY INSECTS, FUNGI, OOMYCETES, BACTERIA OR NEMATODES - The invention consists in modifying the levels of accumulation and emission of monoterpenes and sesquiterpenes in citrus as a mechanism to achieve systemic resistance against pathogens or repellency against pests. The alteration of the content of d-limonene and other terpenes is achieved by genetic transformation via the introduction of a gene that encodes an enzyme with d-limonene synthase activity, from a citrus fruit or plant or from another living organism, in antisense or RNAi (RNA interference) configuration. Genetic modification is achieved either by | 05-19-2011 |
Victoria Santa Fe, Manchester, NH US
Patent application number | Description | Published |
---|---|---|
20120133072 | FULLY-CURED THERMALLY OR ELECTRICALLY CONDUCTIVE FORM-IN-PLACE GAP FILLER - Application of a thermally and/or electrically conductive compound to fill a thermal and/or EMI shielding gap between a first and a second surface. A supply of a fluent, form-stable compound is provided as an admixture of a cured polymer gel component, and a particulate filler component. An amount of the compound is dispensed from a nozzle, screen, stencil, or other orifice under an applied pressure onto one of the surfaces which, when opposed, form the gap, or into the gap formed between the surfaces. The gap is at least partially filled by at least a portion of the dispensed compound. | 05-31-2012 |
Victoria Selma García, Espinardo (murcia) ES
Patent application number | Description | Published |
---|---|---|
20130266932 | METHOD AND ASSOCIATED SYSTEM FOR DETECTION AND ANALYSIS OF PATHOGENS AND/OR AGENTS ABLE TO CAUSE DETERIORATION IN PLANT FOODS - The present invention relates to a method for the detection of potentially pathogenic agents and/or capable of causing deterioration in a plant sample, representative of one or several batches of plant product, characterized in that it comprises the concentration of a plant sample by centrifugation and the analysis of the presence or amount of potentially pathogenic agents and/or capable of causing deterioration in the concentrated sample obtained. Likewise, the present invention relates to a system for detection and analysis of potentially pathogenic agents and/or capable of causing deterioration in a plant sample to carry out said method. | 10-10-2013 |
Victoria Selma García, Espinardo (murcia) ES
Patent application number | Description | Published |
---|---|---|
20130266932 | METHOD AND ASSOCIATED SYSTEM FOR DETECTION AND ANALYSIS OF PATHOGENS AND/OR AGENTS ABLE TO CAUSE DETERIORATION IN PLANT FOODS - The present invention relates to a method for the detection of potentially pathogenic agents and/or capable of causing deterioration in a plant sample, representative of one or several batches of plant product, characterized in that it comprises the concentration of a plant sample by centrifugation and the analysis of the presence or amount of potentially pathogenic agents and/or capable of causing deterioration in the concentrated sample obtained. Likewise, the present invention relates to a system for detection and analysis of potentially pathogenic agents and/or capable of causing deterioration in a plant sample to carry out said method. | 10-10-2013 |
Victoria Sevillano Gonzalez, Salamanca ES
Patent application number | Description | Published |
---|---|---|
20110319472 | METHODS OF PROGNOSTICATING AND TREATING EWING SARCOMA/PNET AND OTHER NEOPLASMS - A method of distinguishing between Ewing sarcoma patients having a good prognosis relative to those having a poor prognosis by screening for specific genomic copy number alterations (CNA) isolated and/or measuring denticleless homolog (Drosophila) (DTL) protein levels from the tumors of patients diagnosed with Ewing Sarcoma. | 12-29-2011 |
Victoria Sharma, Orinda, CA US
Patent application number | Description | Published |
---|---|---|
20080199492 | Env Polypeptide Complexes and Methods Of Use - Provided herein are small molecule CD4 mimetics effective to bind to HIV Env proteins. A CD4 mimetic of the invention, when bound to an Env protein, is effective to induce a conformational change in the Env protein such that cyptic epitopes on the Env protein are exposed. Also provided herein are related methods of identifying and using such small molecule CD4 mimetics, for example, to elicit an immune response in a subject upon administration. | 08-21-2008 |
20080300385 | Covalently-linked complexes of HIV Tat and Env proteins - Complexes of HIV Env and Tat proteins are advantageous as immunogens compared to Tat or Env alone, but they may dissociate when combined with a vaccine adjuvant. To avoid dissociation, complexes of Env and Tat are stabilized by the use of covalent cross linking. The extent of cross linking is important to the binding properties of the complexes, and so is controlled to avoid the loss of Env's ability to bind specifically to CD4 and Tat's ability to bind specifically to anti-Tat monoclonal antibodies. | 12-04-2008 |
20100183653 | Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof - Fusion proteins comprising CD4 minimal modules that bind to HIV Env polypeptides in a non-CD4 backbone are described. Also described are complexes of these fusion proteins with Env as well as methods of diagnosis, treatment and prevention using the polynucleotides and polypeptides are also provided. | 07-22-2010 |
20120177657 | FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND METHODS OF USE THEREOF - Fusion proteins comprising CD4 minimal modules that bind to HIV Env polypeptides in a non-CD4 backbone are described. Also described are complexes of these fusion proteins with Env as well as methods of diagnosis, treatment and prevention using the polynucleotides and polypeptides are also provided. | 07-12-2012 |
20120276141 | ENV POLYPEPTIDE COMPLEXES AND METHODS OF USE - Provided herein are small molecule CD4 mimetics effective to bind to HIV Env proteins. A CD4 mimetic of the invention, when bound to an Env protein, is effective to induce a conformational change in the Env protein such that cyptic epitopes on the Env protein are exposed. Also provided herein are related methods of identifying and using such small molecule CD4 mimetics, for example, to elicit an immune response in a subject upon administration. | 11-01-2012 |
Victoria Siriett, Fairview Downs NZ
Patent application number | Description | Published |
---|---|---|
20090324590 | MYOSTATIN ANTAGONISTS - An isolated recombinant polypeptide having myostatin antagonist activity, comprising a C-terminally truncated mature myostatin peptide, wherein the C-terminal truncation is at a position at or between amino acids 281 and 329, or a fragment, variant or derivative thereof. | 12-31-2009 |
Victoria Siskavich, Lyon Mountain, NY US
Patent application number | Description | Published |
---|---|---|
20110294845 | PARENTERAL FORMULATIONS - This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent. | 12-01-2011 |
20130040980 | CCI-779 CONCENTRATE FORMULATIONS - This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent. | 02-14-2013 |
20130252998 | CCI-779 FORMULATIONS FOR PARENTERAL ADMINISTRATION - This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent. | 09-26-2013 |
Victoria Sluzky, Corte Madera, CA US
Patent application number | Description | Published |
---|---|---|
20080207626 | STABLE TABLET FORMULATION - The present invention is directed to a stable solid formulations of tetrahydrobiopterin, processes for producing them, and treatment methods using such formulations. | 08-28-2008 |
Victoria Smith, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20140186340 | Methods and Compositions for Normalization of Tumor Vasculature by Inhibition of LOXL2 - Disclosed herein are methods and compositions for increasing perfusion, reducing hypoxia, reducing permeability and increasing the integrity of vasculature; e.g., in a tumor. The compositions include inhibitors of the LOXL2 enzyme. In certain of the methods, a LOXL2 inhibitor is used in combination with, and facilitates the therapeutic activity of, an anti-neoplastic agent. | 07-03-2014 |
20140206017 | LYSYL OXIDASE-LIKE 2 ASSAY AND METHODS OF USE THEREOF - The present disclosure provides an assay to detect and/or quantify circulating lysyl oxidase-like 2 (LOXL2) poly-peptides in an individual. The assay is useful in diagnostic and prognostic applications, which are also provided. | 07-24-2014 |
Victoria Smith, Dundee GB
Patent application number | Description | Published |
---|---|---|
20110312921 | N-Myristoyl Transferase Inhibitors - The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors. | 12-22-2011 |
Victoria Smith, Burtingame, CA US
Patent application number | Description | Published |
---|---|---|
20130149298 | Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 06-13-2013 |
Victoria Soghomonian, Blacksburg, VA US
Patent application number | Description | Published |
---|---|---|
20110210294 | ELECTRICALLY CONDUCTING MICROPOROUS FRAMEWORKS - Electrically conducting vanadium arsenate or vanadium phosphate materials are described. The materials include a vanadium arsenate or vanadium phosphate framework structure about organic template and water molecules which may be removed to leave a microporous structure. The three-dimensional vanadium framework may provide electronic conductivity, while the extra-framework constituents may provide ionic conductivity. | 09-01-2011 |
Victoria Song, Porter Ranch, CA US
Patent application number | Description | Published |
---|---|---|
20150026776 | ANONYMOUS SUBJECT IDENTIFICATION SYSTEM - A computerized method and apparatus are established to identify a subject of common interest among multiple parties without releasing the true identity of any subject. Furthermore, a computerized network provides different parties at different locations with a mechanism to conduct cooperative activities concerning such a subject of common interest without exposing that subject to possible identity theft. | 01-22-2015 |
Victoria Spadarogrant, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20110111114 | Grain-Based Powder - A beverage composition comprising dry grain-based powder derived from a cereal mixture. The cereal mixture was cooked during manufacture without enzymes. When mixed with liquid, the dry grain-based powder forms a stable solution with little or no sedimentation for a sufficient duration of time for consumption. | 05-12-2011 |
Victoria Stanbach, Santa Cruz, CA US
Patent application number | Description | Published |
---|---|---|
20130211836 | GLOBAL SPEECH USER INTERFACE - A global speech user interface (GSUI) comprises an input system to receive a user's spoken command, a feedback system along with a set of feedback overlays to give the user information on the progress of his spoken requests, a set of visual cues on the television screen to help the user understand what he can say, a help system, and a model for navigation among applications. The interface is extensible to make it easy to add new applications. | 08-15-2013 |
20140019130 | GLOBAL SPEECH USER INTERFACE - A global speech user interface (GSUI) comprises an input system to receive a user's spoken command, a feedback system along with a set of feedback overlays to give the user information on the progress of his spoken requests, a set of visual cues on the television screen to help the user understand what he can say, a help system, and a model for navigation among applications. The interface is extensible to make it easy to add new applications. | 01-16-2014 |
Victoria Stanbach, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20110270615 | GLOBAL SPEECH USER INTERFACE - A global speech user interface (GSUI) comprises an input system to receive a user's spoken command, a feedback system along with a set of feedback overlays to give the user information on the progress of his spoken requests, a set of visual cues on the television screen to help the user understand what he can say, a help system, and a model for navigation among applications. The interface is extensible to make it easy to add new applications. | 11-03-2011 |
Victoria Stavridou-Coleman, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20100010944 | MANAGING PERSONAL DIGITAL ASSETS OVER MULTIPLE DEVICES - In a first embodiment of the present invention, a method for managing digital assets of a user over multiple home network-enabled devices, the method comprising: receiving information, from a plurality of home network-enabled personal devices, regarding digital assets accessed by the personal devices, wherein the plurality of personal devices are owned or operated by the user and the information is automatically gathered by each personal device tracking its own usage; storing the information; and providing, to one of the plurality of personal devices, identifications of digital assets accessed by the personal devices by accessing the stored information. | 01-14-2010 |
20130275498 | MANAGING PERSONAL DIGITAL ASSETS OVER MULTIPLE DEVICES - In a first embodiment of the present invention, a method for managing digital assets of a user over multiple home network-enabled devices, the method comprising: receiving information, from a plurality of home network-enabled personal devices, regarding digital assets accessed by the personal devices, wherein the plurality of personal devices are owned or operated by the user and the information is automatically gathered by each personal device tracking its own usage; storing the information; and providing, to one of the plurality of personal devices, identifications of digital assets accessed by the personal devices by accessing the stored information. | 10-17-2013 |
Victoria Stratford, Seekonk, MA US
Patent application number | Description | Published |
---|---|---|
20090082114 | INTERACTIVE TRANSFORMING ANIMATED HANDHELD GAME - An interactive handheld electronic game product includes a mechanically transformable casing, which upon mechanical transformation, signals transformation of the functionality of certain inputs as well as aspects of the virtual on-screen environment, e.g. the displayed characters. The transformed functionality of the inputs and the transformed aspects of the virtual environment remain locked or static until further mechanical transformation. A visual display on a frame block displays two or more virtual environments corresponding separately to the first standard configuration and the second extended configuration of the toy block assembly. A user input switch is provided for controlling the displayed virtual environments, and an extension sensor is disposed between the frame block and an extension block. A memory device provides memory segments in communication with a processor responsive to the extension sensor to enable generation of extended configuration inputs with the user input switch for controlling the display in the virtual environment corresponding to the extended configuration. | 03-26-2009 |
Victoria Taylor, Swansea GB
Patent application number | Description | Published |
---|---|---|
20140107069 | PLANT TREATMENT METHOD - A plant treatment method comprising contacting the plant with: (a) a compound of formula (I): or a derivative salt thereof wherein L is a linking group; each of R | 04-17-2014 |
20140171323 | SURFACE TREATMENT METHOD - A method of treating a grass-carrying surface, the method comprising applying to the g carrying surface: (a) a compound of formula (I): or a derivative salt thereof wherein L is a linking group; each of R | 06-19-2014 |
Victoria Vilshenker, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100273122 | Method and intra-oral device for smoking cessation or alcohol cessation - This invention is an improved method and intra-oral device for smoking cessation or alcohol cessation. Specifically, this method requires the use of an intra-oral device comprised of a carbon monoxide sensor, ethanol sensor, sensor supervising and signal processing circuit, power source, electrodes, mounting element. The intra-oral device is used in association with the molar tooth via the mounting element which provides affixation to the device. During the process of smoking, the carbon monoxide sensor of the intra-oral device detects the threshold of carbon monoxide in the smoke entering the mouth. The sensor supervising and signal processing circuit is set into an activation mode, which triggers an electrical stimulation of the neck of the tooth via two electrodes of the device. During the process of alcohol consumption, the ethanol sensor of the intra-oral device detects the threshold of ethanol in the mouth. The sensors supervising and signal processing circuit is set into an activation mode, which triggers an electrical stimulation of the neck of the tooth via two electrodes of the device. The intra-oral device can be programmed in different modes providing varied levels of electrical stimulation via the two electrodes, from slight irritation to light pain which is delivered to the neck of the tooth. This works as negative reinforcement to the smoker or drinker, preventing them from continuation of the smoking session or drinking session. By using one such device the smoker or drinker is behaviorally conditioned to cease further attempts at smoking or drinking. | 10-28-2010 |
Victoria Yamazaki, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20080248492 | Membrane Based Assays - Membrane-based assays using surface detector array devices suitable for use with a biosensor are disclosed. The device is formed of a substrate having a surface defining a plurality of distinct bilayer-compatible surface regions separated by one or more bilayer barrier regions. The bilayer-compatible surface regions carry on them, separated by an aqueous film, supported fluid bilayers. The bilayers may contain selected receptors or biomolecules. A bulk aqueous phase covers the bilayers on the substrate surface. Arrays may be engineered to display natural membrane materials in a native fluid bilayer configuration, permitting high-throughput discovery of drugs that target and affect membrane components. The membrane-based assays detect binding events by monitoring binding-induced changes in one or more physical properties of fluid bilayers. | 10-09-2008 |
Victoria Yang US
Patent application number | Description | Published |
---|---|---|
20080308371 | Luggage bag with removable storage units - A luggage bag comprising a luggage bag housing and separate storage units affixed thereto, wherein the separate storage units are extendable and removable from the luggage bag housing. The luggage bag housing resembles a wheeled luggage bag, duffle bag or tote bag. The separate storage units are of definite shape and collapsible. | 12-18-2008 |